Table 2.
Donor | Acceptor | Productsa |
---|---|---|
C4S | 0S-0S-0S-0S-0S-PA | 4S-0S-0S-0S-0S-0S-PA |
4S-4S-0S-0S-0S-0S-0S-PA | ||
4S-4S-4S-0S-0S-0S-0S-0S-PA | ||
4S-4S-4S-4S-0S-0S-0S-0S-0S-PA | ||
C4S | 0S-0S-0S-0S-PA | 4S-0S-0S-0S-0S-PA |
4S-4S-0S-0S-0S-0S-PA | ||
4S-4S-4S-0S-0S-0S-0S-PA | ||
4S-4S-4S-4S-0S-0S-0S-0S-PA | ||
4S-4S-4S-4S-4S-0S-0S-0S-0S-PA | ||
C4S | 0S-0S-0S-PA | 4S-0S-0S-0S-PA |
4S-4S-0S-0S-0S-PA | ||
4S-4S-4S-0S-0S-0S-PA | ||
4S-4S-4S-4S-0S-0S-0S-PA | ||
4S-4S-4S-4S-4S-0S-0S-0S-PA | ||
C4S | 4S-0S-0S-PA | 4S-4S-0S-0S-PA |
4S-4S-4S-0S-0S-PA | ||
4S-4S-4S-4S-0S-0S-PA | ||
4S-4S-4S-4S-4S-0S-0S-PA | ||
C4S | 0S-4S-4S-PA | 4S-0S-4S-4S-PA |
4S-4S-0S-4S-4S-PA | ||
4S-4S-4S-0S-4S-4S-PA | ||
4S-4S-4S-4S-0S-4S-4S-PA | ||
4S-4S-4S-4S-4S-0S-4S-4S-PA | ||
4S-4S-4S-4S-4S-4S-0S-4S-4S-PA |
The oligosaccharides indicated in the bold are used for the inhibition analysis.